Baillie Gifford & CO Insulet Corp Transaction History
Baillie Gifford & CO
- $126 Billion
- Q1 2024
A detailed history of Baillie Gifford & CO transactions in Insulet Corp stock. As of the latest transaction made, Baillie Gifford & CO holds 1,442,279 shares of PODD stock, worth $291 Million. This represents 0.2% of its overall portfolio holdings.
Number of Shares
1,442,279
Previous 1,212,759
18.93%
Holding current value
$291 Million
Previous $263 Million
6.06%
% of portfolio
0.2%
Previous 0.21%
Shares
2 transactions
Others Institutions Holding PODD
# of Institutions
613Shares Held
62.9MCall Options Held
339KPut Options Held
916K-
Vanguard Group Inc Valley Forge, PA8.2MShares$1.65 Billion0.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.56MShares$1.53 Billion0.3% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$1.22 Billion0.02% of portfolio
-
State Street Corp Boston, MA2.92MShares$589 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA1.99MShares$402 Million0.06% of portfolio
About INSULET CORP
- Ticker PODD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 69,403,600
- Market Cap $14B
- Description
- Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...